Hay Fever Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Hay Fever Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • October 2035
  • Pharmaceutical
  • 0 pages

Report Description

1
1

Hay fever is an allergic disorder caused due to the hyper reaction of the immune cells to pollen grains and airborne substances. It is also called allergic rhinitis. The hyperactivity of the immune cells is due to the presence of high levels of IgE antibodies, which are responsible for release of histamine in the body leading to allergic reactions. Allergic rhinitis is classified into three types: seasonal, perennial, and occupational. Seasonal allergic rhinitis is caused by the hypersensitivity and allergic reaction to the airborne substances such as pollen from grass & weeds and mold spores. Perennial allergic rhinitis is caused by inhalation of dander, pet hair, and dust mites. Occupational allergic rhinitis is characterized by intermittent or persistent symptoms of allergic rhinitis due to work environment. Common symptoms of allergic rhinitis include sneezing, watery eyes, itchy throat, and blocked and runny nose. Serious symptoms include headache, facial pain due to blocked sinuses, and spreading itchiness to nose and ear through throat. Some patients may also experience irritability, tiredness, and insomnia.

Allergic rhinitis is the fifth most common disease in the U.S. According to the American College of Allergy, Asthma & Immunology (ACAAI), 30% of global population is affected by allergic rhinitis. In the U.S., around 30 million people aged around 18 years and above were diagnosed with allergic rhinitis in 2016, accounting for 8.2% of the adult population. Furthermore, around 9%, or 6.1 million, children were diagnosed with allergic rhinitis, most common being the seasonal rhinitis occurring more often in summer, spring, and fall. The cost for treatment of allergic rhinitis in the U.S. is estimated at US$ 3.4 Bn

Major drivers of the Hay Fever market include rising prevalence of the allergy and changing lifestyle leading to decreased immune resistance. However, patent expiration, generic drug competition, and increasing shift from prescription products to OTC products restrain the allergic rhinitis market.

Based on drug class or treatment type, the global Hay Fever market has been segmented into decongestants, antihistamines, corticosteroids, leukotriene receptor antagonists, and immunotherapy (allergy shots). Antihistamines hold the major share of 60% of the allergic rhinitis market, as these are the preferred treatment option by physicians. Moreover, wide range of antihistamines are available for treatment of intermittent symptoms.

In terms of disease type, the global Hay Fever market has been classified into seasonal, perennial, and occupational. The seasonal allergic rhinitis segment holds major share of the market as it is the most common form of allergic rhinitis and occurs in around 20% of the allergic rhinitis patients. Occupational allergic rhinitis is quite rare and can be avoided with the change of working environment.

Based on route of administration, the market has been segmented into oral, intranasal, and intravenous. Intranasal is the preferred route of administration for allergic rhinitis as it would provide immediate relief from intermittent symptoms. Technological advancement is anticipated to boost the intranasal segment.

In terms of distribution channel, the global Hay Fever market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies hold the major share of the Hay Fever market as antihistamines are mostly prescribed for allergic rhinitis which is an OTC product. However, the online pharmacies segment is anticipated to experience moderate growth driven by advancements in technology.

In terms of region, the global Hay Fever market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The U.S. accounted for over 40% share of the Hay Fever market. The trend is projected to continue during the forecast period. However, growth is expected to be sluggish due to market saturation and generic competition. The market in Latin America is anticipated to experience moderate growth due to rising incidence of allergic rhinitis and the expanding immunotherapy market in Mexico and Brazil.

Major players in the global Hay Fever market are Sanofi, UCB, GlaxoSmithKline plc, Merck & Co, Inc., Meda Pharmaceuticals, Johnson & Johnson, Teva Pharmaceuticals, Novartis AG, Kyowo Hako Kirin, and Stallergenes Greer plc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074